Related Experiment Videos
[Pediatric rhabdomyosarcoma of the infratemporal fossa]
1Service d'ORL et de chirurgie cervico-faciale, Institut Gustave Roussy Villejuif, France.
Insights
Rhabdomyosarcoma of the infratemporal fossa has a poor prognosis. Achieving local control is key to survival, with surgery potentially improving outcomes when combined with chemotherapy and radiotherapy.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Rhabdomyosarcoma of the infratemporal fossa (ITF) presents a significant challenge in pediatric oncology.
- The prognosis for ITF rhabdomyosarcoma is historically poor, necessitating novel treatment strategies.
Purpose of the Study:
- To evaluate the treatment outcomes and prognostic factors for pediatric patients with rhabdomyosarcoma of the infratemporal fossa.
- To assess the role of different therapeutic modalities, including radiotherapy and surgery, in managing ITF rhabdomyosarcoma.
Main Methods:
- A retrospective analysis of 23 children diagnosed with ITF rhabdomyosarcoma between 1984 and 1999.
- Patients were categorized into three groups based on treatment: radiotherapy alone, surgery with or without radiotherapy, and chemotherapy alone.
- Outcomes were assessed based on local recurrence, metastatic failure, and overall survival.
Main Results:
- The overall survival rate in the studied cohort was 50%.
- Radiotherapy alone resulted in a high rate of local recurrence and mortality.
- Surgical intervention, particularly when combined with adjuvant therapies, showed potential for improved local control and survival.
Conclusions:
- Local tumor control is the most critical prognostic factor for survival in ITF rhabdomyosarcoma.
- Multidisciplinary approaches integrating surgery, chemotherapy, and radiotherapy are essential for optimizing treatment.
- Consideration of surgical resection for residual tumors post-chemotherapy and tailored postoperative radiotherapy based on pathological findings are crucial.
Objective:
Prognosis of rhabdomyosarcoma of the infratemporal fossa is generally poor. We report our experience.
Material And Methods:
Twenty-three children with rhabdomyosarcoma of the infratemporal fossa were treated at the Gustave Roussy and Curie Institutes between 1984 and 1999. Seventeen children received radiotherapy (group 1), four children were treated surgically with or without postoperative radiotherapy (group 2), and two children received no further treatment after chemotherapy (group 3).
Results:
In group 1, there were 10 local recurrences and one metastatic failure; all 11 children died from their disease. Nodal recurrence was salvaged successfully in one other with chemotherapy and surgery. In group 2, three children were disease free at 3 years and one died of local recurrence. In group 3, one child experienced a local recurrence successfully salvaged with radiotherapy. This child was disease free at 3 years. The other child developed local recurrence and died.
Discussion:
Overall survival rate in our patients was 50%. Local control remained the main prognostic factor for survival. Surgery has already been shown to improve local control in other localizations of rhabdomyosarcoma. If residual tumor tissue remains after neo-adjuvant chemotherapy, surgery should be considered in a multidisciplinary discussion of therapeutic options. Indications for postoperative radiotherapy depend on age and histological features of the surgical specimen.